Efficacy, safety and mechanism of Simiaoyongan decoction in the treatment of carotid atherosclerotic plaque: a randomized, double-blind, placebo-controlled clinical trial protocol

Abstract Introduction Chronic inflammation is the major pathological feature of Atherosclerosis(As). Inflammation may accelerate plaque to develop, which is a key factor resulting in the thinning of the fibrous cap and the vulnerable rupture of plaque. Presently, clinical treatments are still lackin...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	QinHua Fan, ZhongJian Tan, WenQuan Su, QingXiao Li, Dian Jin, YaWei Du, LiPing Zhang, ShengXian Wu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2024-07-01
Saila:	BMC Complementary Medicine and Therapies
Gaiak:	Simiaoyongan Decoction (SMYA) Atherosclerosis (As) High resolution magnetic resonance imaging (HR-MRI) Traditional Chinese medicine (TCM) Randomized controlled trial
Sarrera elektronikoa:	https://doi.org/10.1186/s12906-024-04555-6
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!